Mark Robert Warne
Chief Executive Officer at DEEPMATTER GROUP PLC
Net worth: 2 011 $ as of 2024-03-30
Profile
Mark Warne is currently Chief Executive Officer of DeepMatter Group Plc and a Non-Executive Director on the Board of Ixico Plc.
Mark is widely recognised in the UK and International life sciences sector, having previously spent almost 10 years at IP Group Plc, a leading intellectual property commercialisation company, where he led the Healthcare team.
He managed a portfolio of £330m of net assets in 2016/2017 and represented IP Group on the boards of both listed and private companies.
In 2018, concurrent with the integration of Touchstone Innovations into IP Group, Mark became a Partner in the Life Sciences division.
He joined IP Group from pre-clinical drug discovery CRO, Exelgen, where he was Managing Director.
Mark spent eight years at Exelgen (formerly Tripos Discovery Research) where he also held positions in licensing and strategic affairs, project management and research.
He has a PhD in Computational Chemistry, an MSc in Colloid Science and a BSc in Chemistry, all from the University of Bristol.
Mark is a Chartered Chemist and member of the Royal Society of Chemistry.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IXICO PLC
0.04% | 2023-12-03 | 19,650 ( 0.04% ) | 2 011 $ | 2024-03-30 |
Mark Robert Warne active positions
| Companies | Position | Start |
|---|---|---|
| DEEPMATTER GROUP PLC | Chief Executive Officer | 2018-07-01 |
| IXICO PLC | Director/Board Member | 2016-09-15 |
Azellon Ltd.
 Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The private company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Director/Board Member | 2016-03-31 |
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Director/Board Member | - |
| DegraSense Ltd. | Director/Board Member | - |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Corporate Officer/Principal | 2011-03-15 |
Angelini Ventures SpA
 Angelini Ventures SpA Investment ManagersFinance Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy. | Consultant / Advisor | - |
Former positions of Mark Robert Warne
| Companies | Position | End |
|---|---|---|
| HVIVO PLC | Director/Board Member | 2020-12-30 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Mark Robert Warne
| University of Bristol | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| IXICO PLC | Commercial Services |
| IP GROUP PLC | Commercial Services |
| HVIVO PLC | Commercial Services |
| Private companies | 15 |
|---|---|
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
Receptor Research Ltd.
 Receptor Research Ltd. Chemicals: Major DiversifiedProcess Industries Part of Tripos, Inc., Receptor Research Ltd. provides drug discovery informatics products and services. The private company is based in Bude, UK. Receptor Research was acquired by Tripos, Inc. on November 18, 1997. | Process Industries |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Commercial Services |
Capsant Neurotechnologies Ltd.
 Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Capsant Neurotechnologies Ltd. provided pre-clinical assay services to the drug development industry. It offered in-vitro tissue based screening technologies based on ex-vivo tissues and reaggregated 3D systems. The firm significantly reduced the costs associated with pre-clinical drug development and shortening the overall decision process in the selection of lead candidates for clinical evaluation. The company was founded by Lars Eric Sundstrom, Ashley Ker Pringle and John Edward Chad on June 21, 2002 and was headquartered in Gray's Inn, the United Kingdom. | Health Technology |
DeepMatter Group Plc
 DeepMatter Group Plc Packaged SoftwareTechnology Services DeepMatter Group Plc is engaged in the development of a number of projects targeting new chemicals, materials, formulations, and pharmaceuticals in commercial areas. It operates through the following segments: DeepMatter and InfoChem. The DeepMatter segment owns, develops and is in the early stage of exploiting intellectual property, software, hardware and data analysis capabilities combined as a visionary, disruptive platform called DigitalGlassware, enabling step changes in productivity and discovery for scientists in the pharma and life science sectors. The InfoChem segment develops and commercialises cheminformatics software to handle, store and retrieve chemical structures and reactions for application in pharma, life sciences, and scientific publications. The company was founded by Jon-Paul Griffiths and Mark G. Moloney on June 13, 2006 and is headquartered in Glasgow, the United Kingdom. | Technology Services |
Azellon Ltd.
Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Azellon Ltd. develops stem cell therapy for the repair of avascular meniscal tears. The firm's meniscal repair technology combines bone marrow stem cells with a special membrane that helps to deliver the cells into the injured site. The company was founded by Anthony Hollander and Troels Jordansen in 2007 and is headquartered in London, the United Kingdom. | Commercial Services |
Crysalin Ltd.
 Crysalin Ltd. BiotechnologyHealth Technology Crysalin Ltd. develops crysalin lattice technology for protein structure determination. Its portfolio includes crysalins, a protein-based nanotechnology for application in protein structure determination, as well as biosensor development and optoelectronics. The company was founded by Martin Noble and John Sinclair in June 2007 and is headquartered in Oxfordshire, the United Kingdom. | Health Technology |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Health Technology |
Activiomics Ltd.
 Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Commercial Services |
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The private company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Technology Services |
Optimal Medicine Ltd.
 Optimal Medicine Ltd. Packaged SoftwareTechnology Services Optimal Medicine Ltd. offers individualized clinical decision support software for mental health disorders. The firm’s products include ADHD care, behavioral health, and rheumatoid arthritis. Its products employ clinical and genetic information about an individual patient to generate information that guides physicians on the treatment for that patient. The company was founded by Janet Munro and Robert McBurney in 2009 and is headquartered in Newcastle-upon-Tyne, the United Kingdom. | Technology Services |
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Angelini Ventures SpA
Angelini Ventures SpA Investment ManagersFinance Angelini Ventures SpA (Angelini Ventures) is a venture capital firm founded in 2022. The firm is headquartered in Rome, Italy. | Finance |
| DegraSense Ltd. | |
Ubiquigent Ltd.
 Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Ubiquigent Ltd. develops reagents, kits, drug discovery assay development and compound profiling services to the academic and commercial life science research community worldwide. It focus; namely the ubiquitin, ubiquitin-like and integrated signalling systems. The company has established its scientific and business credentials with both academic researchers undertaking fundamental scientific discovery as well as with pharmaceutical and biotechnology company scientists undertaking ubiquitin system-focused drug discovery. Ubiquigent was founded by Jason Brown in 2009 and is headquartered in Dundee, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Mark Robert Warne
